Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Poised To Hit $2.78 Billion By 2030 With A 12.9% CAGR
The renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market has expanded quickly in recent years. This market is projected to expand from $1.52 billion in 2025 to $1.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. Historically, this expansion is attributable to various factors such as an increase in preclinical drug safety testing, a rise in nephrotoxicity related drug failures, the expansion of CRO services, heightened regulatory safety requirements, and broader adoption of in vitro assays.
The renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market size is projected to experience substantial growth over the next few years. It is anticipated to reach $2.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This expansion during the forecast period is primarily fueled by the increasing number of biologics and complex drugs, the widespread adoption of predictive toxicology models, the ongoing expansion of organ on chip platforms, advancements in precision medicine research, and the rising demand for AI-based safety analytics. Key emerging trends expected within this period include kidney organoid-based toxicity assays, AI-assisted nephrotoxicity prediction models, high-throughput renal screening platforms, biomarker-driven renal safety panels, and microphysiological kidney-on-chip systems.
Get A Free Sample Report With In-Depth Market Insights:
Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of kidney ailments is anticipated to drive the expansion of the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market in the future. These conditions are characterized by damage to the kidneys, compromising their ability to filter blood and maintain the body’s equilibrium. The rise in kidney-related disorders is linked to the growing incidence of diabetes, which harms renal blood vessels and hinders their filtering capacity. Renal toxicity ADME/toxicology testing plays a crucial role in identifying and assessing potential kidney damage resulting from various drugs or chemicals, thereby facilitating prompt intervention and the creation of safer therapeutic options. For instance, in 2025, according to the American Cancer Society, a US-based professional organization, approximately 80,980 new cases of kidney (renal) cancer are expected to be diagnosed in the US, with an estimated 14,510 deaths resulting from the disease. Consequently, the escalating prevalence of kidney-related disorders is propelling the growth of the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market.
Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Segments: Where Is Growth Concentrated?
The renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market covered in this report is segmented –
1) By Test Type: In Vitro Renal Toxicity Testing; In Vivo Renal Toxicity Testing; In Silico Renal Toxicity Modeling
2) By Method: Biochemical and Enzymatic Assays; Cell Based Renal Assays; Biomarker Based Toxicity Analysis; Histopathology and Imaging; Pharmacokinetic and Drug Metabolism Studies
3) By Stage of Drug Development: Discovery and Lead Optimization; Preclinical Development; Clinical Development; Post Marketing Safety Studies
4) By Technology: High Throughput Screening Platforms; Organ On Chip and Microfluidic Systems; Omics Based Toxicology Platforms; Artificial Intelligence and Predictive Modeling Tools; Digital Pathology and Imaging Systems
5) By End User: Pharmaceutical and Biotechnology Companies; Contract Research Organizations; Academic and Research Institutes; Regulatory Laboratories
Subsegments:
1) By In Vitro Renal Toxicity Testing: Primary Renal Cell Assays; Immortalized Renal Cell Line Assays; Three Dimensional Renal Cell Cultures; Kidney Organoid Models; Transporter Interaction Assays; Biomarker Based Nephrotoxicity Assays; High Content Imaging Assays; Microphysiological Kidney System Models
2) By In Vivo Renal Toxicity Testing: Acute Renal Toxicity Studies; Subacute Renal Toxicity Studies; Subchronic Renal Toxicity Studies; Chronic Renal Toxicity Studies; Renal Biomarker Evaluation Studies; Histopathological Kidney Assessment; Dose Response Toxicity Studies; Recovery and Reversibility Studies
3) By In Silico Renal Toxicity Modeling: Quantitative Structure Activity Relationship Modeling; Machine Learning Based Toxicity Prediction; Physiologically Based Pharmacokinetic Modeling; Virtual Screening for Nephrotoxicity; Read Across Toxicity Modeling; Systems Biology Based Toxicity Modeling
Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Trends Powering Strategic Industry Growth
Leading companies in the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market are prioritizing the development of innovative solutions, such as low-drug-absorbing microfluidic chips, to enhance the predictive accuracy of kidney toxicity while reducing dependence on animal testing. A low-drug-absorbing microfluidic chip refers to a lab-on-a-chip device specifically designed for renal toxicity assessment that minimizes unintended drug absorption by its material, thereby ensuring a more accurate simulation of kidney functions and reliable measurement of drug effects on renal cells. For instance, in September 2024, Emulate Inc., a US-based biotechnology company, introduced the chip-R1 rigid chip, aiming to improve kidney toxicity testing with more accurate and reliable outcomes. This chip is engineered for precise ADME and toxicology modeling in non-stretch organs like the liver and kidney, utilizing low-drug-absorbing plastics and a thin, porous polycarbonate membrane to prevent compound loss and enhance drug recovery for lipophilic compounds. Its benefits include robust high shear stress support (up to 2.3 dyn/cm²), preactivated surfaces for streamlined workflows, and improved cellular crosstalk, while advantages encompass better reproducibility, accurate toxicity detection, and compatibility with existing organ-chip hardware to accelerate human-relevant preclinical testing.
Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Key Participants And Competitive Landscape
Major companies operating in the renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Pharmaron Beijing Co. Ltd., Simulations Plus Inc., GVK Biosciences Pvt. Ltd., Promega Corporation, Syngene International Ltd., SAI Life Sciences Ltd., QPS Holdings LLC, Southern Research Institute, BioIVT LLC, TCG Lifesciences Pvt. Ltd., Frontage Laboratories Inc., Symeres, TSRL Inc., BOC Sciences LLC, Vivisciences Preclinical CRO.
View The Full Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Report:
Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the renal toxicity-ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model